C12N 2710/22041
Use of virus, viral particle or viral elements as a vector
C12N2710/22041 (Use of virus, viral particle or viral elements as a vector) appears on 45 US grants and 59 published applications in this corpus.
Search patents in C12N- Granted patents
- 45
- Published applications
- 59
- Assignees
- 32
- Inventors
- 113
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 1 | 1 |
| 2002 | 3 | 3 |
| 2003 | 2 | 1 |
| 2004 | 2 | 2 |
| 2005 | 0 | 4 |
| 2006 | 0 | 1 |
| 2007 | 1 | 2 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 1 | 1 |
| 2011 | 1 | 3 |
| 2012 | 2 | 2 |
| 2013 | 1 | 1 |
| 2014 | 1 | 4 |
| 2015 | 1 | 2 |
| 2016 | 1 | 4 |
| 2017 | 2 | 3 |
| 2018 | 2 | 3 |
| 2019 | 3 | 5 |
| 2020 | 0 | 1 |
| 2021 | 0 | 4 |
| 2022 | 2 | 1 |
| 2023 | 0 | 3 |
| 2024 | 0 | 0 |
| 2025 | 5 | 4 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2710/22043Viral genome or elements thereof as genetic vectorIndexing code35
- C12N 2710/22042Virus or viral particle as vehicleIndexing code9
- C12N 2710/22045Special targeting system for viral vectorsIndexing code3
- C12N 2710/22044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code1
Recent patents
- Composition for regulating production of interfering ribonucleic acid24 Mar 2026US 12,584,129 B1Wyvern Pharmaceuticals Inc.
- Composition for regulating production of interfering ribonucleic acid23 Dec 2025US 12,503,697 B1Wyvern Pharmaceuticals Inc.
- Composition for regulating production of interfering ribonucleic acid2 Dec 2025US 12,486,506 B1Wyvern Pharmaceuticals Inc.
- Composition for regulating production of interfering ribonucleic acid25 Nov 2025US 12,480,121 B1Wyvern Pharmaceuticals Inc.
- Nucleic acid origami structure encapsulated by capsid units27 May 2025US 12,312,594 B2Geza Ad Ltd.
- Method for production of virus-like particles for gene delivery27 Aug 2026US 2026/0250644 A1Carnegie Mellon University
- Composition and method for the production of polyomaviral vector particles13 Aug 2026US 2026/0234658 A1Amarna Holding B.V.
- Composition for regulating production of interfering ribonucleic acid26 Mar 2026US 2026/0085312 A1Wyvern Pharmaceuticals Inc.
- Polyomaviral gene delivery vector particle comprising a nucleic acid sequence encoding a phosphatase activity-possessing polypeptide29 May 2025US 2025/0170272 A1Amarna Holding B.V.
- Probe for universal detection of circulating tumor cells29 May 2025US 2025/0172561 A1
Most cited
By later US patents
- Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes185US 5,316,931 ABiosource Genetics Corporation · 1994
- Recombinant plant viral nucleic acids105US 5,589,367 ABiosource Technologies, Inc. · 1996
- Recombinant plant viral nucleic acids86US 5,866,785 ABiosource Technologies, Inc. · 1999
- Recombinant plant viral nucleic acids73US 5,889,190 ABiosource Technologies, Inc. · 1999
- Cytoplasmic inhibition of gene expression by viral RNA42US 6,479,291 B2Large Scale Biology Corporation · 2002